Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05940857 · ClinicalTrials.gov registry record

US National OCS Liver Perfusion (OLP) Registry

A clinical trial of Liver Transplant, sponsored by TransMedics.

Recruiting
Registry status
100,000
Enrollment target
20
Study locations

NCT05940857 is a study of Liver Transplant that is actively recruiting participants, run by TransMedics. The registered enrollment target is 100,000 participants, above the 195-participant average among 19 other Liver Transplant trials with a reported enrollment target (51182% higher). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05940857, a study of Liver Transplant, is actively recruiting participants, sponsored by TransMedics.

RECRUITING
Registry status
100,000 participants
Enrollment target
20
Study locations

Study Summary

This Registry is a sponsor-initiated, multi-center, observational, post-approval registry with an independent academic oversight. TransMedics has contracted with United Network for Organ Sharing (UNOS) the Federal manager of the U.S. national transplant outcomes registry to obtain data that is routinely collected by the Organ Procurement and Transplantation Network (OPTN) on all transplanted organs in the U.S. for both the OCS liver transplanted patients as well as patients transplanted using other preservation modalities. Additional data will be collected by participating centers using OCS Liver perfusion.

Conditions Studied

Liver Transplant

Interventions

  • DEVICE OCS Liver

Study Locations (20)

California

  • University of California San Diego - La Jolla
  • University of California San Francisco - San Francisco

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston
  • Lahey Clinic Medical Center - Burlington

Michigan

  • University of Michigan Medical Center - Ann Arbor
  • Henry Ford Hospital - Detroit

North Carolina

  • Carolinas Medical Center/Atrium Health - Charlotte
  • Duke Medical Center - Durham

Texas

  • UT Southwestern Medical Center - Dallas
  • Houston Methodist - Houston

Alabama

  • University of Alabama - Birmingham

Arizona

  • Mayo Clinic Hospital Arizona - Phoenix

Florida

  • Mayo Clinic Hospital Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 100,000 participants
Start Date 2021-10-14
Est. Completion 2031-10

Sponsor

TransMedics

23 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05940857

The ClinicalTrials.gov registry entry for NCT05940857 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 195-participant average among 19 other Liver Transplant trials with a reported enrollment target (51182% higher). The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Liver Transplant appearing as the primary indexed condition, and to 1 intervention - of which OCS Liver is the first listed.

NCT05940857 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Massachusetts, Michigan.

Frequently Asked Questions

What is clinical trial NCT05940857 about?

NCT05940857 is a clinical study titled "US National OCS Liver Perfusion (OLP) Registry". This Registry is a sponsor-initiated, multi-center, observational, post-approval registry with an independent academic oversight. TransMedics has contracted with United Network for Organ Sharing (UNOS) the Federal manager of the U.S. national transplant outcomes registry to obtain data that is rout...

What is the current status of trial NCT05940857?

This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2021-10-14. Estimated completion is 2031-10.

What conditions does trial NCT05940857 study?

This clinical trial studies the following conditions: Liver Transplant.

What interventions are being tested in trial NCT05940857?

The interventions under investigation include: OCS Liver (DEVICE).

Who is sponsoring clinical trial NCT05940857?

This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05940857 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Liver Transplant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Liver Transplant

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.